Human immunodeficiency virus-associated nephropathy: a primary care perspective.
The advent of highly active antiretroviral therapy represents a significant advance in medical care for human immunodeficiency virus (HIV)-infected persons. However, not everyone has derived the expected benefits of antiretroviral therapy and HIV-associated diseases such as nephropathy still occur in at-risk populations. Currently, there are no recommendations for screening HIV-positive patients for HIV-associated nephropathy. We propose semiannual screening for proteinuria in HIV-positive African Americans and patients with a family history of renal disease, and provide an algorithm for evaluation.
Olatinwo
Toyin
T
Division of General Medicine, School of Medicine, State University of New York, Buffalo, NY 14215, USA.
Hewitt
Ross G
RG
Venuto
Rocco C
RC
D016263:AIDS-Associated Nephropathy / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D005923:Glomerulosclerosis, Focal Segmental / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D006801:Humans; D011320:Primary Health Care; D051437:Renal Insufficiency / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D012307:Risk Factors; D014481:United States / Q000453:epidemiology